Skip to Main Content

Author Details

Paul T Spellman
Oregon Health & Science University Hospital.
1998
130
54
PMIDPaper TitleJournal TitlePublished Year
36824803An open protocol for modeling T Cell Clonotype repertoires using TCRβ CDR3 sequences.Res Sq2023
36824803An open protocol for modeling T Cell Clonotype repertoires using TCRβ CDR3 sequences.Res Sq2023
36889927Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation.Cold Spring Harb Mol Case Stud2023
36993424Supervised learning of high-confidence phenotypic subpopulations from single-cell data.bioRxiv2023
37506692Population screening shows risk of inherited cancer and familial hypercholesterolemia in Oregon.Am J Hum Genet2023
37506692Population screening shows risk of inherited cancer and familial hypercholesterolemia in Oregon.Am J Hum Genet2023
36993424Supervised learning of high-confidence phenotypic subpopulations from single-cell data.bioRxiv2023
36889927Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation.Cold Spring Harb Mol Case Stud2023
35243422An omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancer.Cell Rep Med2022
35468987Plasma cell-free RNA profiling distinguishes cancers from pre-malignant conditions in solid and hematologic malignancies.NPJ Precis Oncol2022
35243422An omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancer.Cell Rep Med2022
35468987Plasma cell-free RNA profiling distinguishes cancers from pre-malignant conditions in solid and hematologic malignancies.NPJ Precis Oncol2022
33466369The Feasibility of Patient-Specific Circulating Tumor DNA Monitoring throughout Multi-Modality Therapy for Locally Advanced Esophageal and Rectal Cancer: A Potential Biomarker for Early Detection of Subclinical Disease.Diagnostics (Basel)2021
33466369The Feasibility of Patient-Specific Circulating Tumor DNA Monitoring throughout Multi-Modality Therapy for Locally Advanced Esophageal and Rectal Cancer: A Potential Biomarker for Early Detection of Subclinical Disease.Diagnostics (Basel)2021
33886505The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer.JCI Insight2021
33510149Proliferative polyploid cells give rise to tumors via ploidy reduction.Nat Commun2021
34677363Plasma Lipidomic Patterns in Patients with Symptomatic Coronary Microvascular Dysfunction.Metabolites2021
34381935Polygenic Breast Cancer Risk for Women Veterans in the Million Veteran Program.JCO Precis Oncol2021
33510149Proliferative polyploid cells give rise to tumors via ploidy reduction.Nat Commun2021
33886505The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer.JCI Insight2021
34381935Polygenic Breast Cancer Risk for Women Veterans in the Million Veteran Program.JCO Precis Oncol2021
34677363Plasma Lipidomic Patterns in Patients with Symptomatic Coronary Microvascular Dysfunction.Metabolites2021
32565715Deep Functional and Molecular Characterization of a High-Risk Undifferentiated Pleomorphic Sarcoma.Sarcoma2020
32144193Reciprocal monoallelic expression of ASAR lncRNA genes controls replication timing of human chromosome 6.RNA2020
31911616Multiregion exome sequencing of ovarian immature teratomas reveals 2N near-diploid genomes, paucity of somatic mutations, and extensive allelic imbalances shared across mature, immature, and disseminated components.Mod Pathol2020
33199705Transient commensal clonal interactions can drive tumor metastasis.Nat Commun2020
33020547Diurnal stability of cell-free DNA and cell-free RNA in human plasma samples.Sci Rep2020
32565715Deep Functional and Molecular Characterization of a High-Risk Undifferentiated Pleomorphic Sarcoma.Sarcoma2020
31911616Multiregion exome sequencing of ovarian immature teratomas reveals 2N near-diploid genomes, paucity of somatic mutations, and extensive allelic imbalances shared across mature, immature, and disseminated components.Mod Pathol2020
33199705Transient commensal clonal interactions can drive tumor metastasis.Nat Commun2020
33020547Diurnal stability of cell-free DNA and cell-free RNA in human plasma samples.Sci Rep2020
32144193Reciprocal monoallelic expression of ASAR lncRNA genes controls replication timing of human chromosome 6.RNA2020
30930117Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets.Cancer Cell2019
30811916Alternative Splicing in Tumors - A Path to Immunogenicity?N Engl J Med2019
30833418Circulating tumor DNA dynamics using patient-customized assays are associated with outcome in neoadjuvantly treated breast cancer.Cold Spring Harb Mol Case Stud2019
30930117Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets.Cancer Cell2019
30811916Alternative Splicing in Tumors - A Path to Immunogenicity?N Engl J Med2019
30833418Circulating tumor DNA dynamics using patient-customized assays are associated with outcome in neoadjuvantly treated breast cancer.Cold Spring Harb Mol Case Stud2019
29331515MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collection.J Proteomics2018
30232459Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer.Nat Commun2018
29661779Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017.Clin Cancer Res2018
29438696The Integrated Genomic Landscape of Thymic Epithelial Tumors.Cancer Cell2018
29749794Molecular Cytogenetics Guides Massively Parallel Sequencing of a Radiation-Induced Chromosome Translocation in Human Cells.Radiat Res2018
29550076Long-Term Correction of Diabetes in Mice by In Vivo Reprogramming of Pancreatic Ducts.Mol Ther2018
29331515MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collection.J Proteomics2018
30232459Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer.Nat Commun2018
29550076Long-Term Correction of Diabetes in Mice by In Vivo Reprogramming of Pancreatic Ducts.Mol Ther2018
29749794Molecular Cytogenetics Guides Massively Parallel Sequencing of a Radiation-Induced Chromosome Translocation in Human Cells.Radiat Res2018
29438696The Integrated Genomic Landscape of Thymic Epithelial Tumors.Cancer Cell2018
29661779Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017.Clin Cancer Res2018
  • 1 - 50 of 260

Recommended Authors

University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 11
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 17
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 10
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 7
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 0
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 4
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 36
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 33
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 74
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 5
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 13
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 44
Monash University
Career Start Year 2000
Number of shared co-authors 6
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 13
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 2
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year 1999
Number of shared co-authors 17
University of Oslo
Career Start Year 1997
Number of shared co-authors 20
The Ohio State University
Career Start Year 1997
Number of shared co-authors 2
Hospital Sirio-Libanes
Career Start Year 1994
Number of shared co-authors 6
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 7
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 34
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 11
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 24
Medical College of Georgia
Career Start Year 1990
Number of shared co-authors 19
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 11
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 16
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 29
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 14
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Career Start Year 1974
Number of shared co-authors 44

Collaborators

Oregon Health and Science University
Co-authored papers 54
Oregon Health Sciences University
Co-authored papers 18
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 13
Co-authored papers 13
Co-authored papers 12
University of California san francisco
Co-authored papers 12
Co-authored papers 10
Oregon Health & Science University
Co-authored papers 10
Co-authored papers 10
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 9
European Bioinformatics Institute
Co-authored papers 9
University of California san francisco
Co-authored papers 8
Genentech Inc.
Co-authored papers 8
Co-authored papers 8
Walter and Eliza Hall Institute of Medical Research
Co-authored papers 7
Harvard T. H. Chan School of Public Health
Co-authored papers 7
Washington University
Co-authored papers 7
Co-authored papers 7
Calico Life Sciences LLC
Co-authored papers 6
European Bioinformatics Institute
Co-authored papers 6
Howard Hughes Medical Institute, University of California Berkeley
Co-authored papers 5
Co-authored papers 5
Oregon Health and Science University
Co-authored papers 5
Oregon Health & Science University
Co-authored papers 4
Max-Planck-Institut fur Immunbiologie
Co-authored papers 4
University of California San Francisco
Co-authored papers 4
Oregon Health and Science University
Co-authored papers 4
Co-authored papers 4
University of California Davis Health
Co-authored papers 4
Global Health Institute, Ecole Polytechnique Federale de Lausanne (EPFL)
Co-authored papers 4